SavedAdd your journal

Journals / Medical Network Klinik Bilimler ve Doktor / 2005 / Cilt: 11 - Sayı: 3

Effects of intravenous ritodrine tocolysis for preterm labor on maternal serum glucose level

Erken doğum tehtidinde intravenöz ritodrin tedavisinin maternal serum glukoz düzeyine etkisi

Fuat AKERCAN
Teksin ÇIRPAN
Levent AKMAN
Mustafa Coşan TEREK
Hüseyin YILMAZ
Mustafa ULUKUŞ
Pages
297–299
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: While the tocolytic therpay of ritodrine causes a rise in the plasma glucoe level at the 6th hour, the rise decreases at the 12th hour.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the present study is to determine the effect of ritodrine on plasma glucose levels in pregnant women when used as a tocolytic drug.
📊
Key Findings & Data:Plasma glucose levels were measured before and at the 6th and 12th hours after the administration of tocolysis.
💡
Conclusion & Impact:Conclusion: While the tocolytic therpay of ritodrine causes a rise in the plasma glucoe level at the 6th hour, the rise decreases at the 12th hour.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Obstetrik doğum · prematür · Glukoz

Abstract

Objective: The aim of the present study is to determine the effect of ritodrine on plasma glucose levels in pregnant women when used as a tocolytic drug. Material and methods: Twenty pregnant women who were having intravenous ritodrine tocolysis beacuse of preterm labor were included for the study. Plasma glucose levels were measured before and at the 6th and 12th hours after the administration of tocolysis. Results: The mean age of the patients was 27.2±5 and the mean gestational age 30.2±3 weeks. Premature rupture of membranes was present in three cases and multiple pregnancy in one case. The mean plasma glucose levels were 160±16 mg/dl And 131±7 mg/dl at the 6th and 12th hours respectively, whiche were significantly different form the baseline value of 83±13 mg/dl (p<0.05). Conclusion: While the tocolytic therpay of ritodrine causes a rise in the plasma glucoe level at the 6th hour, the rise decreases at the 12th hour.

Özet

Amaç: Bu çalışmamızın amacı, erken doğum nedeniyle tokolitik ilaç olarak intravenöz ritodrinin, gebelerde serum glukoz düzeyine etkilerini araştırmaktır. Gereç ve Yöntem: Kliniğimizde, erken doğum tehdidi nedeniyle intravenöz ritodrin tedavisi alan 20 gebeyi inceledik. Gebelerden, ritodrin başlamadan hemen önce, altıncı ve onikinci saatlerde serum glukoz ölçümleri yapıldı. Bulgular: Hastaların ortalama yaşı 27.2±5 ve ortalama gebelik haftaları 30.2±3 bulundu. Hastaların üçünde (%15) erken membran rüptürü ve bir hastada (5%) çoğul gebelik mevcuttu. Hastaların altı ve onikinci saatlerde ölçülen kan glukoz düzeyleri (160±16mg/dl ve 131±7 mg/dl), intravenöz ritodrin başlamadan önceki kan glukoz düzeylerine (83±13 mg/dl) göre belirgin olarak yüksek saptandı (p<0.05). Sonuç: Intravenöz ritodrin, tedaviden 6-9 saat sonra glukoz düzeyinde artışa neden olsa da 12 saat sonra glukoz düzeylerinde düşüş izlenir.

🔖

Cite This Article

AKERCAN, F., ÇIRPAN, T., AKMAN, L., TEREK, M. C., YILMAZ, H., ULUKUŞ, M. (2005). Effects of intravenous ritodrine tocolysis for preterm labor on maternal serum glucose level. Medical Network Klinik Bilimler ve Doktor, Cilt: 11 - Sayı: 3, 297–299. https://ajindex.com/articles/278381

References (9)

  1. Caughey AB, Parer JT. Tocolysis with beta-adrenergic receptor agonists. Semin Perinatol. 2001; 25:248-55
  2. Rozenberg P. Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review J Gynecol Obstet BiolReprod 2001; 30:221-30
  3. Besinger R.E, lannuci TA. Tocolytic therapy. In: M.G. Elder, R. Romero and R.F. Lamont, Editors, Preterm labor, Churchil Livingstone, New York 1997:243-97
  4. Leveno KJ, Cunningham FG. beta-Adrenergic agonists for preterm labor. New Engl J Med 1992; 327:349-51 5. Bassett JM, Burks AH, Levine DH, Pinches RA, Visser GH. Maternal and fetal metabolic effects of prolonged ritodrine infusion Obstet Gynecol. 1985; 66:755-61
  5. Hirai M, Yasuhi I, Ishimaru T, Yamabe T, Kubota K. Effect of prolonged intravenous ritodrine tocolysis on diurnal glucose profiles in pregnant women With normal carbohydrate tolerance Nippon Sanka Fujinka Gakkai Zasshi. 1996; 48:488-94
  6. Ragni N, Costa M, Bentivoglio G, Pinto PF, Repetti F. Effects of orally administered ritodrine on carbohydrate and lipid metabolism in pregnant patients with abnormal glucose tolerance.Biol Res Pregnancy Perinatol. 1984; 5:42-6
  7. Schreyer P, Caspi E, Snir E, Herzianu E, User P, Gilboa Y, Zaidman JL. Metabolic effects of intramuscular and oral administration of ritodrine in pregnancy. Obstet Gynecol. 1981; 57:730-3
  8. Schreyer P, Caspi E, Arieli S, Maor J, Modai D. Metabolic effects of intravenous ritodrine infusion in pregnancy. Acta Obstet Gynecol Scand. 1980; 59:197-201
  9. Papatsonis DNM, van Geijn HP, Bleker OP, Ader HJ and Dekker GA Hemodynamic and metabolic effects after nifedipine and ritodrine tocolysis Int J Gynecol Obstet 2003; 82:5-10.